ABCC1 p.Asn19Gln

[switch to full view]
Comments [show]
Publications
PMID: 16914551 [PubMed] Chen Q et al: "The amino terminus of the human multidrug resistance transporter ABCC1 has a U-shaped folding with a gating function."
No. Sentence Comment
196 It is also noteworthy that the mutants ABCC1FLAG-Q and ABCC1QQ , with the mutation of Asn19 to Gln, which is the last residue in the IU5C1 epitope, are still reactive to IU5C1 (Fig. 4, M and T).
X
ABCC1 p.Asn19Gln 16914551:196:86
status: NEW
Login to comment

PMID: 9295302 [PubMed] Hipfner DR et al: "Membrane topology of the multidrug resistance protein (MRP). A study of glycosylation-site mutants reveals an extracytosolic NH2 terminus."
No. Sentence Comment
66 The N19Q, N1006Q, and N1156Q mutations were generated using the TransformerTM site-directed mutagenesis kit (CLONTECH Laboratories, Inc., Palo Alto, CA) based on the method developed by Deng and Nickoloff (35).
X
ABCC1 p.Asn19Gln 9295302:66:4
status: NEW
Login to comment

67 The templates for mutagenesis were prepared by cloning the BamHI fragment as above (for N19Q) and the XmaI fragment (MRP nucleotides 2337-4322) (for N1006Q and N1156Q) from pcDNAI-MRP1 into pGEM®-3Z (Promega, Madison, WI).
X
ABCC1 p.Asn19Gln 9295302:67:4
status: NEW
X
ABCC1 p.Asn19Gln 9295302:67:88
status: NEW
Login to comment

68 Mutagenesis was then performed according to the manufacturer`s instructions using the ScaI/ StuI and SspI/EcoRV selection primers (for N19Q and N1006Q/N1156Q mutations, respectively), and the following sense mutagenic oligonucleotide primers: 5Ј-C TGG GAC TGG CAG GTC ACG TGG-3Ј (N19Q), 5Ј-C CCC ATC GTC CAG GGG ACT CAG G-3Ј (N1006Q), and 5Ј-C TAT TCC CAT TTC CAG GAG ACC TTG C-3Ј (N1156Q).
X
ABCC1 p.Asn19Gln 9295302:68:88
status: NEW
X
ABCC1 p.Asn19Gln 9295302:68:135
status: NEW
X
ABCC1 p.Asn19Gln 9295302:68:292
status: NEW
Login to comment

69 The N19Q/N23Q double mutant was also generated by this method using the N19Q mutagenic primer with the N23Q BamHI fragment in pGEM¾1;-3Z as a template.
X
ABCC1 p.Asn19Gln 9295302:69:4
status: NEW
X
ABCC1 p.Asn19Gln 9295302:69:72
status: NEW
X
ABCC1 p.Asn19Gln 9295302:69:135
status: NEW
X
ABCC1 p.Asn19Gln 9295302:69:280
status: NEW
Login to comment

72 The N19Q/N23Q/N1006Q triple mutant was prepared by cloning the BamHI fragment containing the N19Q/N23Q mutation into pcDNAI-MRP1/N1006Q.
X
ABCC1 p.Asn19Gln 9295302:72:4
status: NEW
X
ABCC1 p.Asn19Gln 9295302:72:93
status: NEW
Login to comment

164 Introduction of the individual N19Q, N23Q, and N71Q mutations in MSD1 did not result in a detectable alteration of the electrophoretic mobility of the intact proteins (Fig. 4A, lanes 3-5).
X
ABCC1 p.Asn19Gln 9295302:164:31
status: NEW
Login to comment

165 However, after digestion with trypsin, the N-2 fragments of wild-type MRP and MRP-(N71Q) co-migrated at 43-60 kDa, whereas the N-2 fragments of MRP-(N19Q) and MRP-(N23Q) migrated slightly faster at approximately 38-50 kDa (Fig. 4B, lanes 2-5).
X
ABCC1 p.Asn19Gln 9295302:165:149
status: NEW
Login to comment

166 The MRP-(N19Q) and MRP-(N23Q) N-2 fragments are glycosylated because they have lower electrophoretic mobility than the deglycosylated 25-kDa N-2 fragment of wild-type MRP (compare with Fig. 4B, lane 1).
X
ABCC1 p.Asn19Gln 9295302:166:9
status: NEW
Login to comment

168 To confirm that Asn19 and Asn23 are the only glycosylated sites in MSD1, we also produced an N19Q/N23Q MRP double mutant.
X
ABCC1 p.Asn19Gln 9295302:168:93
status: NEW
Login to comment

169 MRP-(N19Q/ N23Q) migrated faster than wild-type MRP and the N19Q, N23Q, and N71Q single mutants (Fig. 4A, compare lane 6 with lanes 2-5).
X
ABCC1 p.Asn19Gln 9295302:169:5
status: NEW
X
ABCC1 p.Asn19Gln 9295302:169:60
status: NEW
Login to comment

178 A, crude membrane proteins from Cos-1 cells expressing wild-type MRP (WT) treated with (ϩ) or without (-) PNGase F, the single glycosylation site mutant MRP constructs N19Q, N23Q, N71Q, N1006Q, and N1156Q, the double mutant N19Q/N23Q, and the triple mutant N19Q/N23Q/N1006Q were separated by SDS-polyacrylamide gel electrophoresis on 5% gels and immunoblotted with mAb QCRL-1.
X
ABCC1 p.Asn19Gln 9295302:178:168
status: NEW
X
ABCC1 p.Asn19Gln 9295302:178:174
status: NEW
X
ABCC1 p.Asn19Gln 9295302:178:224
status: NEW
X
ABCC1 p.Asn19Gln 9295302:178:230
status: NEW
X
ABCC1 p.Asn19Gln 9295302:178:257
status: NEW
X
ABCC1 p.Asn19Gln 9295302:178:263
status: NEW
Login to comment

70 The N19Q/N23Q double mutant was also generated by this method using the N19Q mutagenic primer with the N23Q BamHI fragment in pGEMt-3Z as a template.
X
ABCC1 p.Asn19Gln 9295302:70:4
status: NEW
X
ABCC1 p.Asn19Gln 9295302:70:72
status: NEW
Login to comment